uterus, fallopian tubes, ovary Flashcards
histo of endometritis
acute: neutros in gland and inflammatory cells in stroma
chronic: plasma cells, may be hemosiderin
* may prevent pregnancy
endometriosis pathogenesis and epi
epi: repro age women (40-50), a/w infertility
hypotheses: retrograde menstruation w implantation, pelvic peritoneum metaplasia, lymphovascular invasion
endometriosis histo
serosal surface dull w adhesions, “chocolate” cysts
endometrial glands and/or stroma, hemosiderin-laden MFs, abundant scarring
endometriosis clinical
asymptomatic or severe pelvic pain w menstruation, dyspareunia, dysuria, pain on defecation
hormonal therapy or surgery
ablation of ovaries eradicates disease
adenomyosis
endometrial glands and stroma in myometrium, causes thickened myometrium
endometrial polyp pathogenesis and clinical
unknown- may be local hyperresponsiveness to estrogen or failure to respond to progesterone
asymptomatic or abnormal bleeding, removal is curative
endometrial polyp gross and histo
gross: pedunculated or sessile, usually soft; varied size, may protrude through os
histo: glands (proliferative to hyperplastic and irregular), dense fibrous stroma, thickened vessels with fibrotic walls, glands may be atrophic
simple endometrial hyperplasia etiology
a/w unopposed estrogen (usually endogenous d/t adipose)
a/w granulosa and other estrogen-producing tumors and PCOS
a/w obesity, DM, HTN
simple endometrial hyperplasia pathogenesis and clinical
continued proliferation of endometrium
no progesterone = no maturation of endometrium = no menses
asymptomatic or abnormal bleeding
simple endometrial hyperplasia gross and histo
gross: plush, thick, tan endometrium
histo: increased gland:stroma ratio, crowded and dilated glands, pseudostratified nuclei w mitotic activity and nucleoli, retain orientation
complex endometrial hyperplasia etiology and pathogenesis
a/w unopposed estrogen, may be exogenous or endogenous (obesity)
a/w granulosa and estrogen-producing tumors and PCOS
estrogen and no progesterone = no maturation of endometrium = no menses
complex endometrial hyperplasia epi and clinical
obese post-menopausal women
a/w DM, HTN
asymptomatic or abnormal bleeding
complex endometrial hyperplasia histo
crowded glands often w budding
pseudostratified nuclei w mitotic activity
retain orientation
small nucleoli and normal chromatin
atypical endometrial hyperplasia etiology, pathogenesis, epi, and clinical
same as other endometrial hyperplasias
atypical endometrial hyperplasia gross and histo
plush, thick, tan endometrium
histo: crowded glands +/- dilation or budding
stratified nuclei with mitoses, loss of orientation
prominent nucleoli w hyperchromatic nuclei or nuclear clearing
no necrosis
type 1 endometrial carcinoma/ adenocarcinoma
d/t unopposed estrogen, a/w obesity, HTN, DM
usually endometrioid adenocarcinoma
a/w PTEN mutation
endometrial adenocarcinoma etiology and pathogenesis
etiology same as hyperplasias, but a small group of women w high grade neoplasms lack hyperestrinism
path: continued proliferation d/t estrogen, evental somatic mutations acquired
endometrial adenocarcinoma epi
obese post-menopausal women, a/w DM and HTN, inc age
m/c invasive carcinoma of female genital tract
*not reliably detected on pap smear
endometrial adenocarcinoma gross and histo
fungating, tan mass +/- myometrial involvement
“back to back” glands, stratified nuclei w mitoses, loss of orientation
prominent nucleoli, vesicular nuclei
may be necrosis
endometrial adenocarcinoma clinical
sx: post-menopausal bleeding, others rare and indicate advanced dz
most pts stage 1 at dx and respond to hysterectomy
spread to cervix, myometrium, ovary, LNs, distant sites; death d/t pelvic dz
adenocarcinoma grading
1 - well-differentiated, less than 5% solid growth
2 - mod diff, less than 50% solid growth
3 - poorly diff, predominantly solid growth (over 50%)
type 2 endometrial carcinoma/ sporadic adenocarcinoma
usually occur later than type 1 in setting of atrophy
poorly differentiated
a/w p53 mutations and psommoma bodies; aggressive
usually serous carcinoma
carcinosarcoma (malignant mixed Mullerian tumor)
u/k etiology and pathogenesis
in post-meno women, 1-2% uterine malignancies
post-meno bleeding, spreads to LNs and hematogenously to lungs
tx: surgery, radiation
poor prognosis
carcinosarcoma (malignant mixed Mullerian tumor) gross and histo
gross: fungating intraluminal mass w poorly circumscribed borders, often bulky
hemorrhage and necrosis common
may protrude through os
histo: malignant epi and stroma; adeno and/or squamous carc; stromal sarc or leiomyosarc (homologous) or osteo/chondro/fibro-sarcoma (heterologous)
adenosarcoma
normal glands in malignant endometrial stroma
may be a/w endometriosis outside of uterus